Doyle John Brendan

Track

Insider profile

Performance

Overall performance
0.8
Performance over holding periods
0.8
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Doyle John Brendan's trades of Cognition Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
189.36
Quantity 51,256 +29.1%
Value US$2,226,245
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-20 2026-04-16
B Purchase
51,256 +29.1%
189.36
US$2,226,245 		51,256 +29.1% 189.36 US$2,226,245